{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T02:49:30Z","timestamp":1793760570872,"version":"4.6.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Sichuan Science and Technology Project","award":["2017JY0302"],"award-info":[{"award-number":["2017JY0302"]}]},{"name":"Science and Technology Projectof Sichuan Provincial Health Committee","award":["20PJ121"],"award-info":[{"award-number":["20PJ121"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sichuan province is one of the highest AIDS epidemic provinces in China, with a large number of floating population. The annual number of cases of HIV\/AIDS reported in Sichuan has been the highest province in China for several successive years. There is a lack of widespread and representative data on the distribution of HIV genotypes in Sichuan. We aim to investigate the characteristics of HIV-1 molecular epidemiology and transmitted drug-resistance in newly diagnosed HIV-infected patients in Sichuan, China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>\n                      Archived plasma samples (n\u2009=\u20091524) from HIV-1 newly-diagnosed individuals in April 2019 were selected by cross-sectional investigation from all 21 cities in Sichuan province. Phylogenetic relationship, transmission cluster, and genotypic drug resistance analyses were performed using HIV-1 polymerase (\n                      <jats:italic>pol<\/jats:italic>\n                      ) gene sequences. We also analysed the association of demographic and virological factors with transmitted drug-resistance (TDR) and transmission clusters.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Partial\n                      <jats:italic>pol<\/jats:italic>\n                      gene sequences were obtained from 1297 cases. HIV-1 epidemic strains in Sichuan province: the majority of genotypes were circulating recombinant form (CRF) 07_BC (675, 52.04%), CRF01_AE (343, 26.45%), CRF08_BC (115, 8.87%), CRF85_BC (67, 5.17%), subtype B (33, 2.54%), the other genotypes only accounted for 4.93%, and unique recombinant forms (URFs) (23, 1.77%) were observed in the study, and the difference of age, ethnicity, education, occupation, region and transmission pathway of different genotypes were statistically significant. According to WHO HIVDR surveillance threshold, the level of TDR has reached a medium level, with 72 of 1297 (5.55%) cases carrying drug-resistance mutation sites, TDR mutation frequency to nonnucleoside reverse transcriptase inhibitors (NNRTIs, 3.85%) was much higher than nucleoside reverse transcriptase inhibitors (NRTIs, 0.31%) and protease inhibitors (PIs, 1.70%), and CRF08_BC was a risk factor for TDR (odds ratio, 8.32; 95% CI 4.38\u201315.80 for CRF07_BC, P\u2009&lt;\u20090.05). The most common drug resistance HIV-1 mutation pattern for NNRTI was V106 (1.31%, 17\/1297) and E138 (1.16%, 15\/1297), and for PI was M46 (0.69%, 9\/1297). A total of 205 (15.8%)\n                      <jats:italic>pol<\/jats:italic>\n                      sequences were involved in the genetic transmission network clusters, CRF01_AE (odds ratio, 2.369; 95% CI 1.659\u20133.382;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05), subtype B (odds ratio, 13.723; 95% CI 6.338\u201329.71;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05), drug resistance (odds ratio, 0.306; 95% CI 0.106\u20130.881;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05) and different levels of education (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05) were significantly associated to be in clusters.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The distribution of HIV-1 genotypes in Sichuan is more diverse and complex, and the Men who have sex with men (MSM) is underrated, arguing for behavior scaling up intervention in this specific population besides the elderly people with heterosexual transmission risk groups. The risk of TDR mutation frequency increased in newly diagnosed patients highlights the significance of genotypic drug resistance monitoring and molecular surveillance of pretreatment HIV-1 drug resistance. The regimen composed of TDF, 3TC and EFV was still currently the preferred solution used free first-line therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-022-07576-z","type":"journal-article","created":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T13:11:48Z","timestamp":1657199508000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Characterization of HIV-1 molecular epidemiology and transmitted drug-resistance in newly diagnosed HIV-infected patients in Sichuan, China"],"prefix":"10.1186","volume":"22","author":[{"given":"Chang","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,7]]},"reference":[{"key":"7576_CR1","unstructured":"NCAIDS NCC. National AIDS venereal disease. 2019."},{"issue":"5453","key":"7576_CR2","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1126\/science.287.5453.607","volume":"287","author":"B Hahn","year":"2000","unstructured":"Hahn B, Shaw G, De Cock KM, Sharp P. AIDS as a zoonosis: scientific and public health implications. Science. 2000;287(5453):607\u201314.","journal-title":"Science"},{"issue":"5","key":"7576_CR3","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1097\/QAD.0b013e328342ff93","volume":"25","author":"J Hemelaar","year":"2011","unstructured":"Hemelaar J, Gouws E, Ghys PD, Osmanov S. Global trends in molecular epidemiology of HIV-1 during 2000\u20132007. AIDS (Lond, Engl). 2011;25(5):679\u201389.","journal-title":"AIDS (Lond, Engl)"},{"key":"7576_CR4","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1089\/aid.2016.0029","volume":"32","author":"X Li","year":"2016","unstructured":"Li X, Li W, Zhong P, Fang K, Zhu K, Musa TH, Song Y, Du G, Gao R. Nationwide trends in molecular epidemiology of HIV-1 in China. AIDS Res Hum Retrovir. 2016;32:851\u20139.","journal-title":"AIDS Res Hum Retrovir"},{"key":"7576_CR5","doi-asserted-by":"crossref","unstructured":"Zhao S, Feng Y, Hu J, Li Y, Zuo Z, Yan J, Zhang J, Cao P, Xu W, Li F et al. Prevalence of Transmitted HIV drug resistance in antiretroviral treatment na\u00efve newly diagnosed individuals in China. SCI REP-UK 2018, 8(1).","DOI":"10.1038\/s41598-018-29202-2"},{"issue":"38","key":"7576_CR6","first-page":"300","volume":"5","author":"H Xing","year":"2004","unstructured":"Xing H, Liang H, Wan ZY, Chen X, Wei M, PengFei M, Guan Q, Quan Y, Hong KX, Shao YM. Distribution of recombinant human immunodeficiency virus type-1 CRF01_AE strains in China and its sequence variations in the env V3\u2013C3 region. Chin J Prev Med. 2004;5(38):300\u20134.","journal-title":"Chin J Prev Med"},{"issue":"23","key":"7576_CR7","doi-asserted-by":"publisher","first-page":"11367","DOI":"10.1128\/JVI.74.23.11367-11376.2000","volume":"74","author":"L Su","year":"2000","unstructured":"Su L, Graf M, Zhang Y, Briesen HV, Xing H, Kostler J, Melzl H, Wolf H, Shao Y, Wagner R. Characterization of a virtually full-length human immunodeficiency virus type 1 genome of a prevalent intersubtype (C\/B\u2032) recombinant strain in China. J Virol. 2000;74(23):11367\u201376.","journal-title":"J Virol"},{"issue":"24","key":"7576_CR8","doi-asserted-by":"publisher","first-page":"13591","DOI":"10.1128\/JVI.78.24.13591-13599.2004","volume":"78","author":"L Zhang","year":"2004","unstructured":"Zhang L, Chen Z, Cao Y, Yu J, Li G, Yu W, Yin N, Mei S, Li L, Balfe P, et al. Molecular characterization of human immunodeficiency virus type 1 and hepatitis C virus in paid blood donors and injection drug users in China. J Virol. 2004;78(24):13591\u20139.","journal-title":"J Virol"},{"key":"7576_CR9","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1097\/QAI.0b013e3181c7d363","volume":"53","author":"L Liao","year":"2010","unstructured":"Liao L, Xing H, Shang H, Li J, Zhong P. The prevalence of transmitted antiretroviral drug resistance in treatment-naive HIV-infected individuals in China. J Acquir Immune Defic Syndr. 2010;53:S10-14.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"7576_CR10","doi-asserted-by":"publisher","first-page":"12273","DOI":"10.1038\/s41598-018-29202-2","volume":"8","author":"S Zhao","year":"2018","unstructured":"Zhao S, Yi F, Hu J, Yang L, Zuo Z, Yan J, Zhang J, Cao P, Xu W, Li F. Prevalence of transmitted HIV drug resistance in antiretroviral treatment nave newly diagnosed individuals in China. Sci Rep-UK. 2018;8:12273.","journal-title":"Sci Rep-UK"},{"issue":"12","key":"7576_CR11","first-page":"946","volume":"22","author":"L Su","year":"2016","unstructured":"Su L, Yang H, Hu Y, Ye L, Yuan D, Wei D, Zhou G, Yu J, Liu H, Qin G. Molecular epidemiological study on HIV-1 in Sichuan province in 2014. Chin J AIDS STD. 2016;22(12):946\u20139.","journal-title":"Chin J AIDS STD"},{"issue":"8","key":"7576_CR12","first-page":"831","volume":"26","author":"L Su","year":"2020","unstructured":"Su L, Zhu J, Zeng Y, Hou X, Yan T, Li Y, Yang H, Ye L, Yuan D, Wei D, et al. Epidemiological characteristics of HIV-1 strain in Guangyuan city. Chin J AIDS STD. 2020;26(8):831\u20135.","journal-title":"Chin J AIDS STD"},{"issue":"7","key":"7576_CR13","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1089\/aid.2020.0034","volume":"36","author":"A Dong","year":"2020","unstructured":"Dong A, Liu L, Xiao L, Liang S, Li K, Hu J, Kang R, Xing J, Song C, Yin J, et al. First detection of a circulating recombinant form of HIV-1 CRF01_AE\/08_BC (CRF105_0108) with drug-resistant mutations in Sichuan, China. AIDS Res Hum Retrovir. 2020;36(7):625\u201330.","journal-title":"AIDS Res Hum Retrovir"},{"issue":"9","key":"7576_CR14","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1089\/aid.2016.0053","volume":"32","author":"L Su","year":"2016","unstructured":"Su L, Wei D, Yang H, Zeng Y, Hu Y, Yuan D, Feng L, Ruan Y, Qin G, Liang S. Identification of a Novel HIV-1 circulating recombinant form (CRF85_BC) in Sichuan, China. AIDS Res Hum Retrovir. 2016;32(9):895\u20139.","journal-title":"AIDS Res Hum Retrovir"},{"issue":"7","key":"7576_CR15","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1093\/molbev\/msw054","volume":"33","author":"K Sudhir","year":"2016","unstructured":"Sudhir K, Glen S, Koichiro T. MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets. Mol Biol Evol. 2016;33(7):1870.","journal-title":"Mol Biol Evol"},{"issue":"11","key":"7576_CR16","doi-asserted-by":"publisher","first-page":"e27731","DOI":"10.1371\/journal.pone.0027731","volume":"6","author":"K Liu","year":"2011","unstructured":"Liu K, Randal LC, Tandy W, Wu R. RAxML and FastTree: comparing two methods for large-scale maximum likelihood phylogeny estimation. PLoS ONE. 2011;6(11):e27731.","journal-title":"PLoS ONE"},{"issue":"1","key":"7576_CR17","doi-asserted-by":"publisher","first-page":"11584","DOI":"10.1038\/s41598-017-10286-1","volume":"7","author":"J\u00c1 Pati\u00f1o-Galindo","year":"2017","unstructured":"Pati\u00f1o-Galindo J\u00c1, Torres-Puente M, Alma Bracho M. The molecular epidemiology of HIV-1 in the Comunidad Valenciana (Spain): analysis of transmission clusters. Sci Rep-UK. 2017;7(1):11584.","journal-title":"Sci Rep-UK"},{"issue":"4","key":"7576_CR18","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1080\/10635150600755453","volume":"55","author":"M Anisimova","year":"2006","unstructured":"Anisimova M, Gascuel AO. Approximate likelihood-ratio test for branches: a fast, accurate, and powerful alternative. Syst Biol. 2006;55(4):539\u201352.","journal-title":"Syst Biol"},{"key":"7576_CR19","unstructured":"CDC. Guidance: detecting, investigating, and responding to HIV transmission clusters 2018. Prevention TRCF, editor. 2018."},{"issue":"1","key":"7576_CR20","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1186\/s12879-020-05347-2","volume":"20","author":"D Yuan","year":"2020","unstructured":"Yuan D, Liu M, Li Y, Jia P, Yang S. Genetic transmission networks of HIV-1 CRF07_BC strain among HIV-1 infections with virologic failure of ART in a minority area of China: a population-based study. BMC Infect Dis. 2020;20(1):631.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"7576_CR21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/QAD.0b013e328011e691","volume":"21","author":"RW Shafer","year":"2007","unstructured":"Shafer RW, Rhee SY, Pillay D, Miller V, Sandstrom P, Schapiro JM, Kuritzkes DR, Bennett D. HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance. AIDS. 2007;21(2):215\u201323.","journal-title":"AIDS"},{"issue":"11","key":"7576_CR22","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1086\/503914","volume":"42","author":"TF Liu","year":"2006","unstructured":"Liu TF, Shafer ARW. Web resources for HIV Type 1 genotypic-resistance test interpretation. Clin Infect Dis. 2006;42(11):1608\u201318.","journal-title":"Clin Infect Dis"},{"key":"7576_CR23","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ijid.2019.02.016","volume":"81","author":"Y Qiao","year":"2019","unstructured":"Qiao Y, Xu Y, Jiang D, Wang X, Wang F, Yang J, Wei Y. Epidemiological analyses of regional and age differences of HIV\/AIDS prevalence in China, 2004\u20132016. Int J Infect Dis. 2019;81:215\u201320.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"7576_CR24","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12879-019-3788-7","volume":"19","author":"P Zhou","year":"2019","unstructured":"Zhou P, Yu G, Kuang Y, Huang X, Li Y, Fu X, Lin P, Yan J, He X. Rapid and complicated HIV genotype expansion among high-risk groups in Guangdong Province, China. BMC Infect Dis. 2019;19(1):185.","journal-title":"BMC Infect Dis"},{"issue":"10","key":"7576_CR25","doi-asserted-by":"publisher","first-page":"e75777","DOI":"10.1371\/journal.pone.0075777","volume":"8","author":"L Li","year":"2013","unstructured":"Li L, Sun G, Liang S, Li J, Li T, Wang Z, Liu W, Yang S, Liu Y, Wang X, et al. Different distribution of HIV-1 subtype and drug resistance were found among treatment naive individuals in Henan, Guangxi, and Yunnan province of China. PLoS ONE. 2013;8(10):e75777.","journal-title":"PLoS ONE"},{"issue":"6","key":"7576_CR26","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1521\/aeap.16.6.538.53787","volume":"16","author":"X Li","year":"2004","unstructured":"Li X, Fang XD, Mao R, Wang J, Cottrell L, Harris C, Stanton B. HIV\/STD risk behaviors and perceptions among rural-to-urban migrants in China. AIDS Educ Prev. 2004;16(6):538\u201356.","journal-title":"AIDS Educ Prev"},{"issue":"11","key":"7576_CR27","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1007\/s00705-017-3485-z","volume":"162","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Dai L, Jiang Y, Feng K, Liu L, Xia W, Yu F, Yao J, Xing W, Sun L, et al. Transmission network characteristics based on env and gag sequences from MSM during acute HIV-1 infection in Beijing, China. Arch Virol. 2017;162(11):3329\u201338.","journal-title":"Arch Virol"},{"issue":"28","key":"7576_CR28","doi-asserted-by":"publisher","first-page":"e26640","DOI":"10.1097\/MD.0000000000026640","volume":"100","author":"N Ma","year":"2021","unstructured":"Ma N, Chen X, Zhao Y, Kang X, Pan S, Yao W. HIV-1 molecular transmission network among sexually transmitted populations in Liaoning Province, China. Medicine. 2021;100(28):e26640.","journal-title":"Medicine"},{"issue":"1","key":"7576_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12985-020-1281-y","volume":"17","author":"D Zhang","year":"2020","unstructured":"Zhang D, Wu J, Zhang Y, Shen Y, Dai S, Wang X, Xing H, Lin J, Han J, Li J, et al. Genetic characterization of HIV-1 epidemic in Anhui Province, China. Virol J. 2020;17(1):17.","journal-title":"Virol J"},{"issue":"11","key":"7576_CR30","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1097\/QAD.0b013e328360db2d","volume":"27","author":"Y Feng","year":"2013","unstructured":"Feng Y, He X, Hsi JH, Li F, Li X, Wang Q, Ruan Y, Xing H, Lam TT, Pybus OG, et al. The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s. AIDS. 2013;27(11):1793\u2013802.","journal-title":"AIDS"},{"issue":"8927","key":"7576_CR31","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/S0140-6736(94)92304-3","volume":"344","author":"H Cheng","year":"1994","unstructured":"Cheng H, Zhang J, Capizzi J, Young NL, Mastro TD. HIV-1 subtype E in Yunnan, China. Lancet. 1994;344(8927):953\u20134.","journal-title":"Lancet"},{"issue":"1","key":"7576_CR32","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1128\/JVI.77.1.685-695.2003","volume":"77","author":"R Yang","year":"2003","unstructured":"Yang R, Kusagawa S, Zhang C, Xia X, Ben K, Takebe Y. Identification and characterization of a new class of human immunodeficiency virus type 1 recombinants comprised of two circulating recombinant forms, CRF07_BC and CRF08_BC, China. J Virol. 2003;77(1):685\u201395.","journal-title":"J Virol"},{"issue":"31","key":"7576_CR33","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1089\/aid.2014.0120","volume":"5","author":"L Li","year":"2015","unstructured":"Li L, Wei D, Hsu WL, Li T, Gui T, Wood C, Liu Y, Li H, Bao Z, Liu S, et al. CRF07_BC strain dominates the HIV-1 epidemic in injection drug users in Liangshan Prefecture of Sichuan, China. AIDS Res Hum Retrovir. 2015;5(31):479\u201387.","journal-title":"AIDS Res Hum Retrovir"},{"key":"7576_CR34","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1089\/aid.2016.0087","volume":"32","author":"Y Wang","year":"2016","unstructured":"Wang Y, Ma L, Xu W, Li F, Feng Y, Liang S, Shao Y, Zhang F. Near full-length genome identification of a novel HIV-1 unique (B\/C) recombinant isolate in Sichuan, China. AIDS Res Hum Retrovir. 2016;32:1229.","journal-title":"AIDS Res Hum Retrovir"},{"issue":"7","key":"7576_CR35","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1089\/aid.2015.0276","volume":"32","author":"W Yan","year":"2016","unstructured":"Yan W, Wei H, Xu W, Yin Q, Ma L. Identification of a Novel CRF01_AE\/CRF07_BC recombinant form in Men Who Have Sex with Men in Sichuan, China. AIDS Res Hum Retrovir. 2016;32(7):718.","journal-title":"AIDS Res Hum Retrovir"},{"issue":"1","key":"7576_CR36","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12879-021-05854-w","volume":"21","author":"X Pang","year":"2021","unstructured":"Pang X, Tang K, He Q, Huang J, Fang N, Zhou X, Zhu Q, Wu X, Shen Z, Liang S. HIV drug resistance and HIV transmission risk factors among newly diagnosed individuals in Southwest China. BMC Infect Dis. 2021;21(1):160.","journal-title":"BMC Infect Dis"},{"issue":"17","key":"7576_CR37","first-page":"441","volume":"6","author":"L Liu","year":"2019","unstructured":"Liu L, Dong A, Liao L, Feng Y, Shao Y, Liang S, Ruan Y, Xing H. Survey of pretreatment HIV drug resistance and genetic transmission network analysis among HIV patients in a high drug-use area of Southwest China. Curr HIV Res. 2019;6(17):441\u201351.","journal-title":"Curr HIV Res"},{"issue":"Suppl 1","key":"7576_CR38","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.4081\/idr.2013.s1.e4","volume":"5","author":"KA Lau","year":"2013","unstructured":"Lau KA, Wong J. Current trends of HIV recombination worldwide. Infect Dis Rep. 2013;5(Suppl 1):e4.","journal-title":"Infect Dis Rep"},{"issue":"3","key":"7576_CR39","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.molmed.2011.12.001","volume":"18","author":"J Hemelaar","year":"2012","unstructured":"Hemelaar J. The origin and diversity of the HIV-1 pandemic. Trends Mol Med. 2012;18(3):182\u201392.","journal-title":"Trends Mol Med"},{"issue":"1","key":"7576_CR40","doi-asserted-by":"publisher","first-page":"e00050-12","DOI":"10.1128\/genomeA.00050-12","volume":"1","author":"X Han","year":"2013","unstructured":"Han X, An M, Zhang W, Cai W, Chen X, Takebe Y, Shang H. Genome sequences of a novel HIV-1 circulating recombinant form, CRF55_01B, identified in China. Genome Announc. 2013;1(1):e00050-12.","journal-title":"Genome Announc"},{"issue":"10","key":"7576_CR41","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1089\/aid.2017.0066","volume":"33","author":"Y Li","year":"2017","unstructured":"Li Y, Feng Y, Li F, Xue Z, Hu J, Xing H, Ruan Y, Shao Y. Genome sequence of a novel HIV-1 circulating recombinant form (CRF79_0107) Identified from Shanxi, China. AIDS Res Hum Retrovir. 2017;33(10):1056\u201360.","journal-title":"AIDS Res Hum Retrovir"},{"issue":"10","key":"7576_CR42","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1089\/aid.2013.0137.retract","volume":"29","author":"X Li","year":"2013","unstructured":"Li X, Ning C, Xiang H, Yao Y, Shao Y. Genome sequences of a novel HIV-1 circulating recombinant form (CRF59_01B) identified among MSM in China. AIDS Res Hum Retrovir. 2013;29(10):1395.","journal-title":"AIDS Res Hum Retrovir"},{"issue":"3","key":"7576_CR43","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1128\/genomeA.00315-13","volume":"1","author":"X Han","year":"2013","unstructured":"Han X, An M, Zhang W, Zhao B, Chu Z, Take Be Y, Shang H. Genome sequences of a novel HIV-1 circulating recombinant form (CRF59_01B) identified among men who have sex with men in Northeastern China. Genome Announc. 2013;1(3):1395.","journal-title":"Genome Announc"},{"issue":"2","key":"7576_CR44","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/01.olq.0000187266.29927.11","volume":"33","author":"H Liu","year":"2006","unstructured":"Liu H, Yang H, Li X, Wang N, Liu H, Wang B, Zhang L, Wang Q, Stanton B. Men who have sex with men and human immunodeficiency virus\/sexually transmitted disease control in China. Sex Transm Dis. 2006;33(2):68\u201376.","journal-title":"Sex Transm Dis"},{"issue":"5","key":"7576_CR45","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.jinf.2007.06.015","volume":"55","author":"D Zhang","year":"2007","unstructured":"Zhang D, Bi P, Lv F, Zhang J, Hiller JE. Changes in HIV prevalence and sexual behavior among men who have sex with men in a northern Chinese city: 2002\u20132006. J Infect. 2007;55(5):456\u201363.","journal-title":"J Infect"},{"key":"7576_CR46","volume-title":"Guidelines for surveillance of HIV drug resistance","author":"WHO","year":"2003","unstructured":"WHO. Guidelines for surveillance of HIV drug resistance. Geneva: World Health Organization; 2003."},{"issue":"1","key":"7576_CR47","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1186\/s12879-016-1928-x","volume":"16","author":"H Li","year":"2016","unstructured":"Li H, Chang S, Han Y, Zhuang D, Li L, Liu Y, Liu S, Bao Z, Zhang W, Song H. The prevalence of drug resistance among treatment-na\u00efve HIV-1-infected individuals in China during pre- and post-2004. BMC Infect Dis. 2016;16(1):605.","journal-title":"BMC Infect Dis"},{"issue":"Suppl. 1","key":"7576_CR48","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/QAI.0b013e3181c7d363","volume":"53","author":"L Liao","year":"2010","unstructured":"Liao L, Xing H, Shang H, Li J, Zhong P, Kang L, Cheng H, Si X, Jiang S, Li X. The prevalence of transmitted antiretroviral drug resistance in treatment-naive HIV-infected individuals in China. J Acquir Immune Defic Syndr. 2010;53(Suppl. 1):10\u20134.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"10","key":"7576_CR49","doi-asserted-by":"publisher","first-page":"e110652","DOI":"10.1371\/journal.pone.0110652","volume":"9","author":"Y Su","year":"2014","unstructured":"Su Y, Zhang F, Liu H, Smith MK, Zhu L, Wu J, Wang N. The prevalence of HIV-1 drug resistance among antiretroviral treatment na\u00efve individuals in Mainland China: a meta-analysis. PLoS ONE. 2014;9(10):e110652.","journal-title":"PLoS ONE"},{"key":"7576_CR50","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1007\/s00705-018-3839-1","volume":"163","author":"Y Xu","year":"2018","unstructured":"Xu Y, Peng X, Xiuming J, Shujing C, Bin W. Characterization of HIV-1 subtypes and transmitted drug resistance among treatment-naive HIV-infected individuals in Zhejiang, China, 2014\u20132017. Arch Virol. 2018;163:2233\u20137.","journal-title":"Arch Virol"},{"key":"7576_CR51","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s12879-019-3927-1","volume":"19","author":"Z Wang","year":"2019","unstructured":"Wang Z, Zhang M, Li R, Yinzhong L, Jiangrong S. Diversity of HIV-1 genotypes and high prevalence of pretreatment drug resistance in newly diagnosed HIV-infected patients in Shanghai, China. BMC Infect Dis. 2019;19:313.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"7576_CR52","first-page":"e165110","volume":"12","author":"F Zhang","year":"2017","unstructured":"Zhang F, Li L, Sun M, Sun J, Lu H. An analysis of drug resistance among people living with HIV\/AIDS in Shanghai, China. PLoS ONE. 2017;12(2):e165110.","journal-title":"PLoS ONE"},{"issue":"6","key":"7576_CR53","first-page":"648","volume":"40","author":"AB Dong","year":"2019","unstructured":"Dong AB, Xiao L, Liang S, Liu L, Xing H. HIV-1 drug resistance and influencing factors among people living with HIV\/AIDS before antiretroviral therapy in Liangshan Yi Autonomous Prefecture. Chin J Epidemiol. 2019;40(6):648\u201353.","journal-title":"Chin J Epidemiol"},{"issue":"1","key":"7576_CR54","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12981-020-00264-5","volume":"17","author":"P Liu","year":"2020","unstructured":"Liu P, Xing H, Liao L, Feng Y, Leng X, Wang J, Kan W, Yan J, Li Y, Zuo Z, et al. HIV drug resistance in patients in China\u2019s national HIV treatment programme who have been on first-line ART for at least 9\u00a0months. AIDS Res Ther. 2020;17(1):9.","journal-title":"AIDS Res Ther"},{"issue":"12","key":"7576_CR55","doi-asserted-by":"publisher","first-page":"e166661","DOI":"10.1371\/journal.pone.0166661","volume":"11","author":"Z Zuo","year":"2016","unstructured":"Zuo Z, Liang S, Sun X, Bussell S, Yan J, Kan W, Leng X, Liao L, Ruan Y, Shao Y, et al. Drug resistance and virological failure among HIV-infected patients after a decade of antiretroviral treatment expansion in eight provinces of China. PLoS ONE. 2016;11(12):e166661.","journal-title":"PLoS ONE"},{"issue":"011","key":"7576_CR56","first-page":"858","volume":"27","author":"J Wu","year":"2014","unstructured":"Wu J, Norris J, Liu HX, Li Z, Su YY, Zhu L, Wang N. The prevalence of HIV Drug resistance among treatment-failure individuals and treatment-nave individuals in China: a meta-analysis. Biomed Environ Sci. 2014;27(011):858\u201371.","journal-title":"Biomed Environ Sci"},{"issue":"3","key":"7576_CR57","first-page":"377","volume":"224","author":"B Silvia","year":"2020","unstructured":"Silvia B, Lucas H, Jordan MR, Santiago AR, Collins I, Anne D, Eric D, AnnEmArie W, Theresa A, Borhan A. Clinical impact of pretreatment human immunodeficiency virus drug resistance in people initiating nonnucleoside reverse transcriptase inhibitor containing antiretroviral therapy: a systematic review and meta-analysis. J Infect Dis. 2020;224(3):377\u201388.","journal-title":"J Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07576-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07576-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07576-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T13:12:41Z","timestamp":1657199561000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07576-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,7]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7576"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07576-z","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,7]]},"assertion":[{"value":"4 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the ethics committees of Sichuan Center for Disease Prevention and Control. All participants signed written informed consents prior to sample donations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing financial interests exist.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"602"}}